2cureX receives important ISO 13485:2016 certificationAbout IndiTreat® test
IndiTreat® is for cancer therapy selection
With IndiTreat®, you can test different panels of drugs and drug combinations on microtumors derived from individual patients to identify resistance and sensitivity.
Key benefits of IndiTreat
- Predict tumor resistance and sensitivity to cancer drugs
- Select the most appropriate treatment, in accordance with guidelines or off-label
- Improve patient quality of life through in vitro testing of drug efficacy on the individual patient
- Identify the most effective treatment in chemo-naïve colorectal cancer patients
- Identify the most effective treatment in late-stage colorectal cancer patients
- Complement the genomic characterisation of tumours with functional data on resistance and sensitivity to drugs
Want to know more?
Contact us
Please contact 2cureX for more information
Email: info@2cureX.com
Phone: +45 22115399
Web: www.IndiTreat.com
Upcoming events
September 15, 2021 at 15:00 (CET)
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
September 23, 2021
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
